BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21756913)

  • 1. β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.
    Fajardo G; Zhao M; Berry G; Wong LJ; Mochly-Rosen D; Bernstein D
    J Mol Cell Cardiol; 2011 Nov; 51(5):781-9. PubMed ID: 21756913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.
    Fajardo G; Zhao M; Urashima T; Farahani S; Hu DQ; Reddy S; Bernstein D
    J Mol Cell Cardiol; 2013 Oct; 63():155-64. PubMed ID: 23920331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization With 5-HT
    Song Y; Xu C; Liu J; Li Y; Wang H; Shan D; Wainer IW; Hu X; Zhang Y; Woo AY; Xiao RP
    Circ Res; 2021 Jan; 128(2):262-277. PubMed ID: 33208036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
    Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
    Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy.
    Fajardo G; Zhao M; Powers J; Bernstein D
    J Mol Cell Cardiol; 2006 Mar; 40(3):375-83. PubMed ID: 16458323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro.
    Wang X; Sun Q; Jiang Q; Jiang Y; Zhang Y; Cao J; Lu L; Li C; Wei P; Wang Q; Wang Y
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial disruption occurs downstream from β-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways.
    Branco AF; Sampaio SF; Wieckowski MR; Sardão VA; Oliveira PJ
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2379-91. PubMed ID: 23958426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3β-mediated suppression of mitochondrial permeation pore opening.
    Zhang Y; Xia Z; La Cour KH; Ren J
    Antioxid Redox Signal; 2011 Nov; 15(9):2407-24. PubMed ID: 21542787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
    Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat.
    Merlet N; Piriou N; Rozec B; Grabherr A; Lauzier B; Trochu JN; Gauthier C
    PLoS One; 2013; 8(5):e64711. PubMed ID: 23741376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Ca2+ influx and efflux rates in guinea pig cardiac mitochondria: low and high affinity effects of cyclosporine A.
    Wei AC; Liu T; Cortassa S; Winslow RL; O'Rourke B
    Biochim Biophys Acta; 2011 Jul; 1813(7):1373-81. PubMed ID: 21362444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
    Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
    Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
    Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
    J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.